InsiderTrades.com logo
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
From Crypto Swap Profits   |   Ad
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
>> Register for the Workshop Now

KPTI Insider Trading

Insider Ownership Percentage: 4.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,454,603.97

Karyopharm Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Karyopharm Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Karyopharm Therapeutics Share Price & Price History

Current Price: $0.64
Price Change: ▼ Price Decrease of -0.0146 (-2.25%)
As of 12/20/2024 06:45 PM ET

This chart shows the closing price history over time for KPTI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
From Crypto Swap Profits   |   Ad
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
>> Register for the Workshop Now

Karyopharm Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/4/2024Richard A PaulsonCEOSell3,607$0.88$3,174.161,135,607View SEC Filing Icon  
8/6/2024Richard A PaulsonCEOSell3,608$0.93$3,355.441,142,881View SEC Filing Icon  
7/30/2024Stuart PoultonEVPSell2,883$1.06$3,055.98326,628View SEC Filing Icon  
7/5/2024Richard A PaulsonCEOSell3,616$0.85$3,073.601,146,489View SEC Filing Icon  
6/7/2024Deepika PakianathanDirectorSell231,548$0.95$219,970.60View SEC Filing Icon  
6/5/2024Deepika PakianathanDirectorSell468,044$0.96$449,322.243,385View SEC Filing Icon  
6/4/2024Michael MasonCFOSell652$0.99$645.48398,104View SEC Filing Icon  
6/4/2024Richard A PaulsonCEOSell3,592$0.99$3,556.081,150,105View SEC Filing Icon  
6/3/2024Deepika PakianathanDirectorSell360,744$1.00$360,744.0011,209View SEC Filing Icon  
5/31/2024Deepika PakianathanDirectorSell204,394$0.95$194,174.3014,697View SEC Filing Icon  
5/6/2024Richard A PaulsonCEOSell3,576$1.13$4,040.881,153,697View SEC Filing Icon  
4/22/2024Reshma RangwalaEVPSell6,789$1.17$7,943.13342,931View SEC Filing Icon  
4/4/2024Richard A PaulsonCEOSell3,563$1.29$4,596.271,157,273View SEC Filing Icon  
3/5/2024Richard A PaulsonCEOSell3,573$1.30$4,644.901,160,836View SEC Filing Icon  
2/29/2024Michael ManoSVPSell16,973$1.17$19,858.41281,428View SEC Filing Icon  
2/29/2024Michael MasonCFOSell27,687$1.17$32,393.79404,918View SEC Filing Icon  
2/29/2024Reshma RangwalaEVPSell15,667$1.17$18,330.39355,689View SEC Filing Icon  
2/29/2024Richard A PaulsonCEOSell80,470$1.17$94,149.901,183,783View SEC Filing Icon  
2/27/2024Michael MasonCFOSell2,545$1.32$3,359.40244,400View SEC Filing Icon  
2/15/2024Stuart PoultonEVPSell5,847$1.33$7,776.51163,772View SEC Filing Icon  
2/6/2024Michael MasonCFOSell4,205$1.59$6,685.95246,945View SEC Filing Icon  
2/6/2024Richard A PaulsonCEOSell4,012$1.59$6,379.08821,453View SEC Filing Icon  
1/4/2024Richard A PaulsonCEOSell4,114$0.82$3,373.48783,465View SEC Filing Icon  
12/4/2023Richard A PaulsonCEOSell3,622$0.79$2,861.38787,579View SEC Filing Icon  
11/6/2023Richard A PaulsonCEOSell3,606$0.92$3,317.52791,201View SEC Filing Icon  
10/4/2023Richard A PaulsonCEOSell3,589$1.27$4,558.03794,807View SEC Filing Icon  
9/12/2023Garen G. BohlinDirectorBuy41,140$1.22$50,190.8045,140View SEC Filing Icon  
9/1/2023Michael ManoSVPSell3,888$1.33$5,171.04142,234View SEC Filing Icon  
9/1/2023Michael MasonCFOSell6,913$1.33$9,194.29237,817View SEC Filing Icon  
9/1/2023Sohanya Roshan ChengEVPSell7,415$1.33$9,861.95204,086View SEC Filing Icon  
8/7/2023Richard A PaulsonCEOSell3,722$1.72$6,401.84802,018View SEC Filing Icon  
7/28/2023Stuart PoultonEVPSell2,845$1.70$4,836.50156,286View SEC Filing Icon  
7/5/2023Richard A PaulsonCEOSell3,538$1.72$6,085.36805,740View SEC Filing Icon  
6/8/2023Sohanya Roshan ChengEVPSell1,839$2.35$4,321.65211,501View SEC Filing Icon  
5/4/2023Richard A PaulsonCEOSell3,805$3.35$12,746.75812,814View SEC Filing Icon  
4/20/2023Reshma RangwalaEVPSell6,770$4.05$27,418.50158,230View SEC Filing Icon  
4/4/2023Richard A PaulsonCEOSell3,497$3.97$13,883.09816,619View SEC Filing Icon  
3/6/2023Richard A PaulsonCEOSell3,506$3.16$11,078.96820,116View SEC Filing Icon  
3/1/2023Michael MasonCFOSell11,205$3.03$33,951.15245,361View SEC Filing Icon  
3/1/2023Richard A PaulsonCEOSell33,033$3.03$100,089.99823,622View SEC Filing Icon  
3/1/2023Sohanya Roshan ChengEVPSell11,239$3.03$34,054.17210,687View SEC Filing Icon  
3/1/2023Stephen MitchenerSVPSell6,357$3.03$19,261.71128,313View SEC Filing Icon  
2/15/2023Stuart PoultonEVPSell5,869$3.19$18,722.1164,131View SEC Filing Icon  
1/4/2023Richard A PaulsonCEOSell3,922$3.27$12,824.94608,605View SEC Filing Icon  
12/5/2022Richard A PaulsonCEOSell3,490$5.17$18,043.30612,527View SEC Filing Icon  
11/4/2022Richard A PaulsonCEOSell3,493$4.54$15,858.22616,017View SEC Filing Icon  
10/4/2022Richard A PaulsonCEOSell3,488$5.87$20,474.56619,510View SEC Filing Icon  
9/8/2022Richard A PaulsonCEOSell3,479$5.23$18,195.17622,998View SEC Filing Icon  
8/4/2022Richard A PaulsonCEOSell2,314$4.48$10,366.72626,477View SEC Filing Icon  
7/8/2022Richard A PaulsonCEOSell2,115$5.18$10,955.70628,791View SEC Filing Icon  
6/13/2022Sohanya Roshan ChengInsiderSell1,551$5.21$8,080.7189,949View SEC Filing Icon  
6/10/2022Deepika PakianathanDirectorSell1,307$6.00$7,842.0016,673View SEC Filing Icon  
6/8/2022Deepika PakianathanDirectorSell325,977$6.50$2,118,850.5018,731View SEC Filing Icon  
6/7/2022Richard A PaulsonCEOSell2,542$5.76$14,641.92630,906View SEC Filing Icon  
6/3/2022Michael MasonCFOSell601$6.04$3,630.04138,509View SEC Filing Icon  
2/7/2022Jatin ShahEVPSell1,704$9.86$16,801.44View SEC Filing Icon  
2/7/2022Michael KauffmanDirectorSell6,764$9.86$66,693.04View SEC Filing Icon  
2/7/2022Michael MasonCFOSell3,947$9.86$38,917.42View SEC Filing Icon  
2/7/2022Sharon ShachamInsiderSell6,707$9.86$66,131.02View SEC Filing Icon  
See Full Table
Trump’s Sending THIS Crypto Higher on Purpose
From Crypto 101 Media   |   Ad
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
YES, I WANT THE #1 CRYPTO NOW

SEC Filings (Institutional Ownership Changes) for Karyopharm Therapeutics (NASDAQ:KPTI)

66.44% of Karyopharm Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at KPTI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Karyopharm Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC95,767$79K0.0%-89.0%0.076%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,355,392$1.13M0.0%+3.3%1.082%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC95,767$79K0.0%-89.0%0.076%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC204,750$0.17M0.0%-86.8%0.163%Search for SEC Filing on Google Icon
11/15/2024State Street Corp409,510$0.34M0.0%-9.8%0.327%Search for SEC Filing on Google Icon
11/15/2024Point72 Asia Singapore Pte. Ltd.82,446$68K0.0%-50.1%0.066%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets1,982,354$1.65M0.0%-12.8%1.582%Search for SEC Filing on Google Icon
11/13/2024FMR LLC369,723$0.31M0.0%+26.1%0.295%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP1,775,700$1.47M0.1%+80.6%1.424%Search for SEC Filing on Google Icon
10/10/2024Exchange Traded Concepts LLC218,791$0.18M0.0%+34.9%0.176%Search for SEC Filing on Google Icon
9/16/2024Point72 DIFC Ltd35,939$31K0.0%N/A0.029%Search for SEC Filing on Google Icon
9/16/2024Cubist Systematic Strategies LLC568,975$0.49M0.0%N/A0.456%Search for SEC Filing on Google Icon
9/16/2024Point72 Asia Singapore Pte. Ltd.165,318$0.14M0.0%N/A0.133%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC748,020$0.65M0.0%+494.5%0.600%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.165,318$0.14M0.0%N/A0.133%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC568,975$0.49M0.0%N/A0.457%Search for SEC Filing on Google Icon
8/14/2024Point72 DIFC Ltd35,939$31K0.0%N/A0.029%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP2,580,863$2.25M0.0%-0.6%2.071%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd140,576$0.12M0.0%-42.1%0.113%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC756,227$0.66M0.0%-16.6%0.607%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC194,168$0.17M0.0%N/A0.156%Search for SEC Filing on Google Icon
8/6/2024Los Angeles Capital Management LLC354,020$0.31M0.0%-8.6%0.284%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp166,315$0.14M0.0%-65.9%0.133%Search for SEC Filing on Google Icon
5/17/2024Ikarian Capital LLC409,355$0.62M0.1%+2.3%0.348%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.8,338,401$12.59M0.0%-4.3%7.160%Search for SEC Filing on Google Icon
5/3/2024GSA Capital Partners LLP1,299,151$1.96M0.2%-44.4%1.115%Search for SEC Filing on Google Icon
4/24/2024Simplicity Wealth LLC44,011$66K0.0%N/A0.038%Search for SEC Filing on Google Icon
2/15/2024Birchview Capital LP469,832$0.41M0.3%-17.8%0.410%Search for SEC Filing on Google Icon
2/12/2024Monashee Investment Management LLC132,435$0.12M0.0%N/A0.116%Search for SEC Filing on Google Icon
2/8/2024Panagora Asset Management Inc.227,445$0.20M0.0%N/A0.199%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets1,769,184$1.53M0.0%+6.5%1.545%Search for SEC Filing on Google Icon
2/6/2024Los Angeles Capital Management LLC391,540$0.34M0.0%N/A0.342%Search for SEC Filing on Google Icon
1/29/2024Simplicity Solutions LLC37,938$33K0.0%N/A0.033%Search for SEC Filing on Google Icon
1/25/2024Bleakley Financial Group LLC37,938$33K0.0%N/A0.033%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC73,430$64K0.0%+295.0%0.064%Search for SEC Filing on Google Icon
1/5/2024Exchange Traded Concepts LLC115,864$100K0.0%+34.0%0.101%Search for SEC Filing on Google Icon
11/15/2023Tejara Capital Ltd1,077,388$1.44M0.8%-5.8%0.941%Search for SEC Filing on Google Icon
11/15/2023GSA Capital Partners LLP568,298$0.76M0.1%N/A0.496%Search for SEC Filing on Google Icon
11/14/2023Avidity Partners Management LP8,298,570$11.12M0.4%-0.9%7.246%Search for SEC Filing on Google Icon
11/13/2023Silverarc Capital Management LLC561,955$0.75M0.2%+8.3%0.491%Search for SEC Filing on Google Icon
11/13/2023Tejara Capital Ltd1,077,388$1.44M1.1%-5.8%0.941%Search for SEC Filing on Google Icon
11/8/2023Wade G W & Inc.45,140$60K0.0%N/A0.039%Search for SEC Filing on Google Icon
11/7/2023Quantbot Technologies LP21,699$29K0.0%-60.1%0.019%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC1,152,298$1.54M0.0%+4.2%1.008%Search for SEC Filing on Google Icon
10/18/2023Exchange Traded Concepts LLC86,484$0.12M0.0%+30.2%0.076%Search for SEC Filing on Google Icon
8/15/2023Silverarc Capital Management LLC518,985$0.93M0.3%-66.3%0.454%Search for SEC Filing on Google Icon
8/14/2023Prelude Capital Management LLC15,933$29K0.0%-62.4%0.014%Search for SEC Filing on Google Icon
8/14/2023Graham Capital Management L.P.62,414$0.11M0.0%N/A0.055%Search for SEC Filing on Google Icon
8/11/2023Rubric Capital Management LP919,196$1.65M0.1%-79.3%0.804%Search for SEC Filing on Google Icon
8/11/2023Tejara Capital Ltd1,143,991$2.05M1.0%+128.1%1.000%Search for SEC Filing on Google Icon
8/11/2023Platinum Investment Management Ltd.500,000$0.90M0.0%N/A0.437%Search for SEC Filing on Google Icon
8/11/2023ExodusPoint Capital Management LP2,382,451$4.27M0.0%N/A2.083%Search for SEC Filing on Google Icon
8/9/2023BNP Paribas Arbitrage SNC461,096$0.83M0.0%+24.8%0.403%Search for SEC Filing on Google Icon
8/8/2023AlphaCentric Advisors LLC810,000$1.45M0.8%+237.5%0.708%Search for SEC Filing on Google Icon
8/8/2023Candriam S.C.A.1,435,694$2.57M0.0%-6.5%1.255%Search for SEC Filing on Google Icon
8/7/2023Principal Financial Group Inc.32,838$59K0.0%-32.8%0.029%Search for SEC Filing on Google Icon
8/7/2023Acadian Asset Management LLC98,946$0.18M0.0%N/A0.087%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.54,514$98K0.0%+45.1%0.048%Search for SEC Filing on Google Icon
7/26/2023Simplicity Solutions LLC15,966$29K0.0%N/A0.014%Search for SEC Filing on Google Icon
7/20/2023Exchange Traded Concepts LLC66,422$0.12M0.0%N/A0.058%Search for SEC Filing on Google Icon
7/19/2023Kennedy Investment Group35,000$63K0.0%+75.0%0.031%Search for SEC Filing on Google Icon
7/10/2023SG Americas Securities LLC14,868$27K0.0%-58.5%0.013%Search for SEC Filing on Google Icon
6/1/2023Prelude Capital Management LLC42,427$0.17M0.0%-27.5%0.037%Search for SEC Filing on Google Icon
6/1/2023Kennedy Investment Group20,000$78K0.0%N/A0.018%Search for SEC Filing on Google Icon
5/16/2023Altium Capital Management LP505,781$1.97M1.1%N/A0.444%Search for SEC Filing on Google Icon
5/15/2023Affinity Asset Advisors LLC460,979$1.79M0.6%-30.3%0.404%Search for SEC Filing on Google Icon
5/15/2023Rubric Capital Management LP4,441,056$17.28M0.4%-46.5%3.895%Search for SEC Filing on Google Icon
5/12/2023AlphaCentric Advisors LLC240,000$0.93M0.6%N/A0.211%Search for SEC Filing on Google Icon
5/12/2023Profund Advisors LLC167,517$0.65M0.0%N/A0.147%Search for SEC Filing on Google Icon
5/11/2023Citigroup Inc.730,027$2.84M0.0%+43.5%0.640%Search for SEC Filing on Google Icon
5/11/2023E Fund Management Co. Ltd.51,849$0.20M0.0%+42.0%0.045%Search for SEC Filing on Google Icon
5/10/2023Connor Clark & Lunn Investment Management Ltd.187,450$0.73M0.0%-56.6%0.164%Search for SEC Filing on Google Icon
5/9/2023Russell Investments Group Ltd.94,380$0.37M0.0%-35.4%0.083%Search for SEC Filing on Google Icon
5/4/2023Barclays PLC2,847,389$11.08M0.0%+172.0%2.499%Search for SEC Filing on Google Icon
5/4/2023Mirae Asset Global Investments Co. Ltd.37,398$0.15M0.0%N/A0.033%Search for SEC Filing on Google Icon
5/4/2023Los Angeles Capital Management LLC113,724$0.44M0.0%+11.6%0.100%Search for SEC Filing on Google Icon
5/2/2023Victory Capital Management Inc.11,684$45K0.0%N/A0.010%Search for SEC Filing on Google Icon
4/28/2023SG Americas Securities LLC35,864$0.14M0.0%N/A0.031%Search for SEC Filing on Google Icon
4/27/2023Arizona State Retirement System31,090$0.12M0.0%+53.4%0.027%Search for SEC Filing on Google Icon
4/20/2023Hennion & Walsh Asset Management Inc.139,574$0.54M0.0%-3.3%0.122%Search for SEC Filing on Google Icon
4/20/2023Banque Cantonale Vaudoise15,000$58K0.0%+175.2%0.013%Search for SEC Filing on Google Icon
3/23/2023MetLife Investment Management LLC29,394$100K0.0%-29.0%0.026%Search for SEC Filing on Google Icon
2/15/2023Armistice Capital LLC3,853,565$13.10M0.2%N/A4.748%Search for SEC Filing on Google Icon
2/15/2023Avidity Partners Management LP9,633,911$32.76M0.7%N/A11.871%Search for SEC Filing on Google Icon
2/13/2023ExodusPoint Capital Management LP1,106,132$3.76M0.1%+56.4%1.363%Search for SEC Filing on Google Icon
2/13/2023Martingale Asset Management L P45,315$0.15M0.0%N/A0.056%Search for SEC Filing on Google Icon
2/13/2023GSA Capital Partners LLP82,162$0.28M0.0%N/A0.101%Search for SEC Filing on Google Icon
2/10/2023Opaleye Management Inc.1,206,841$4.28M1.5%N/A1.487%Search for SEC Filing on Google Icon
2/10/2023New York Life Investment Management LLC76,968$0.26M0.0%+12.7%0.095%Search for SEC Filing on Google Icon
2/10/2023Connor Clark & Lunn Investment Management Ltd.432,278$1.47M0.0%+178.1%0.533%Search for SEC Filing on Google Icon
2/10/2023Moors & Cabot Inc.12,200$41K0.0%-42.3%0.015%Search for SEC Filing on Google Icon
2/9/2023Principal Financial Group Inc.56,805$0.19M0.0%+186.5%0.070%Search for SEC Filing on Google Icon
2/9/2023Monashee Investment Management LLC481,696$1.64M0.7%N/A0.594%Search for SEC Filing on Google Icon
2/9/2023Citigroup Inc.508,593$1.73M0.0%-16.3%0.627%Search for SEC Filing on Google Icon
2/8/2023UBS Group AG523,259$1.78M0.0%+364.9%0.645%Search for SEC Filing on Google Icon
2/8/2023Swiss National Bank259,150$0.88M0.0%+52.9%0.319%Search for SEC Filing on Google Icon
2/8/2023Russell Investments Group Ltd.146,160$0.50M0.0%+12.9%0.180%Search for SEC Filing on Google Icon
2/7/2023State Board of Administration of Florida Retirement System27,015$92K0.0%-49.1%0.033%Search for SEC Filing on Google Icon
2/7/2023Fox Run Management L.L.C.28,823$98K0.0%N/A0.036%Search for SEC Filing on Google Icon
2/6/2023Los Angeles Capital Management LLC101,917$0.35M0.0%+29.6%0.126%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Karyopharm Therapeutics logo
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1). Its lead compound, include XPOVIO in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma; in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). It also developing Selinexor for treating hematological and solid tumor malignancies, including multiple myeloma, endometrial cancer, myelofibrosis, and DLBCL; and ELTANEXOR for treating Myelodysplastic Neoplasms, as well as verdinexor, KPT-9274, and IL-12 compounds. The company has license agreement with Menarini Group to develop and commercialize selinexor for human oncology indications; license agreement with Antengene Therapeutics Limited to develop and commercialize selinexor, eltanexor, and KPT-9274 for the treatment and/or prevention of human oncology indications, as well as verdinexor for the diagnosis, treatment, and/or prevention of human non-oncology indications; and distribution agreement for the commercialization of XPOVIO with FORUS Therapeutics Inc. Further, it has a collaboration with Bristol Myers Squibb company to evaluate novel cereblon E3 ligase modulator agent mezigdomide in combination with Selinexor in patients with relapsed/refractory multiple myeloma. Karyopharm Therapeutics Inc. was incorporated in 2008 and is headquartered in Newton, Massachusetts.
Read More on Karyopharm Therapeutics

Today's Range

Now: $0.64
Low: $0.63
High: $0.66

50 Day Range

MA: $0.82
Low: $0.64
High: $0.99

52 Week Range

Now: $0.64
Low: $0.63
High: $1.95

Volume

1,277,004 shs

Average Volume

1,221,216 shs

Market Capitalization

$80.13 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.05

Who are the company insiders with the largest holdings of Karyopharm Therapeutics?

Karyopharm Therapeutics' top insider shareholders include:
  1. Richard A Paulson (CEO)
  2. Michael Mason (CFO)
  3. Reshma Rangwala (EVP)
  4. Stuart Poulton (EVP)
  5. Michael Mano (SVP)
  6. Sohanya Roshan Cheng (EVP)
  7. Stephen Mitchener (SVP)
  8. Garen G Bohlin (Director)
  9. Deepika Pakianathan (Director)
Learn More about top insider investors at Karyopharm Therapeutics.

Who are the major institutional investors of Karyopharm Therapeutics?

Karyopharm Therapeutics' top institutional shareholders include:
  1. BNP Paribas Financial Markets — 1.58%
  2. GSA Capital Partners LLP — 1.42%
  3. Geode Capital Management LLC — 1.08%
  4. State Street Corp — 0.33%
  5. FMR LLC — 0.30%
  6. Exchange Traded Concepts LLC — 0.18%
Learn More about top institutional investors of Karyopharm Therapeutics stock.

Which major investors are selling Karyopharm Therapeutics stock?

Within the previous quarter, KPTI stock was sold by these institutional investors:
  1. Jane Street Group LLC
  2. Barclays PLC
  3. Barclays PLC
  4. BNP Paribas Financial Markets
  5. Point72 Asia Singapore Pte. Ltd.
  6. State Street Corp
Within the last year, company insiders that have sold Karyopharm Therapeutics company stock include:
  1. Richard A Paulson (CEO)
  2. Michael Mason (CFO)
  3. Reshma Rangwala (EVP)
  4. Stuart Poulton (EVP)
  5. Michael Mano (SVP)
  6. Sohanya Roshan Cheng (EVP)
Learn More investors selling Karyopharm Therapeutics stock.

Which major investors are buying Karyopharm Therapeutics stock?

In the last quarter, KPTI stock was purchased by institutional investors including:
  1. GSA Capital Partners LLP
  2. FMR LLC
  3. Exchange Traded Concepts LLC
  4. Geode Capital Management LLC
  5. Wolverine Trading LLC
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
From Crypto Swap Profits   |   Ad
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
>> Register for the Workshop Now